Form 1 T32Meeting feedback survey

OMB # 0925-0648
Expiration Date: 6/30/2024
Public reporting burden for this collection of information is estimated to average 10 minutes per response, including the
time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and
completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not
required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments
regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this
burden, to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (09250642). Do not return the completed form to this address.

Thank you for attending the 10th Annual Meeting of T32 Trainees! Please take a few
minutes to evaluate this meeting. Our goal is to obtain feedback so that we can improve
the next meeting.
Responses are anonymous. As such, we are unable to respond to feedback submitted
here. If you would like a response to a comment or question, please email us at
bpca@infinityconferences.com.

Please select the choice below that best describes your role at this meeting.
Pediatric Clinical Pharmacology Fellow
Other Pediatric Fellow
Adult Clinical Pharmacology Fellow
Other Adult Fellow
Former Fellow
PI/Program Director
Other (FDA, NIH, etc.)

Virtual Meeting Logistics
Were you satisfied with the frequency and quality of pre-meeting communications
regarding virtual participation?
Yes
No
Additional Comments

On a scale of 1 to 5 with 5 being the best, how would you rate the quality of
support received during the virtual meeting?
1 (poor)

Š
Additional Comments

5 (excellent)

Š

Š

Š

Š

N/A

Agenda Feedback
On a scale of 1 to 5, with 5 being the best, how would you rate the following
session on August 16:
1:40-2:40 PM: There and Back Again - Atypical Career Paths (Barrett)
1 (poor)

Š
Additional Comments

5 (excellent)

Š

Š

Š

Š

N/A

Agenda Feedback
On a scale of 1 to 5, with 5 being the best, how would you rate the following
sessions on August 17:
1:35-2:35 PM: Clinical Pharmacology and Regulatory Science at the FDA Opportunities and Career Paths (Schuck)
1 (poor)

Š

5 (excellent)

Š

Š

Š

N/A

Š

Additional Comments

4:55-5:15 PM: Making Drugs Safer and More Effective for Kids: An Overview of the
Pediatric Trials Network (Greenberg)
1 (poor)

Š
Additional Comments

5 (excellent)

Š

Š

Š

Š

N/A

Agenda Feedback
Which career development breakout session did you attend?
Grant Writing/Specific Aims
Mentor-Mentee Mojo
Scientific Publishing
I did not attend a breakout session

On a scale of 1 to 5, with 5 being the best, how would you rate this session.
1 (poor)

Š

5 (excellent)

Š

Š

Š

N/A

Š

Additional Comments

On a scale of 1 to 5, with 5 being the best, how would you rate the usefulness of the
quiz with board-related questions?
1 (poor)

Š
Additional Comments

5 (excellent)

Š

Š

Š

Š

N/A

Please provide your feedback on the fellow presentations.

General Feedback
On a scale of 1 to 5, with 5 being the best, what is your overall rating of the Tenth
Annual Meeting of T32 Trainees?
1 (poor)

Š

5 (excellent)

Š

Š

Š

Š

What is the main reason for your rating?

Please provide any additional comments regarding the virtual meeting format,
agenda content, or logistical support. Include any suggestions for next year’s
meeting.